TOXR

Value Q3, 25Q4, 25 TTM 총매출 —— — Gross profit —— — Operating expenses 1.83 M1.18 M — Selling/general/admin expenses —— — Research & development —— — 영업 이익 -1.83 M-1.18 M — Non-Operating Income, Total 54.71 M-106.57 M — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses 54.71 M-106.57 M — Unusual income/expense —— — Pretax income 52.88 M-107.75 M — Equity in earnings —— — Taxes —— — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 54.71 M-106.57 M — Discontinued operations —— — Net income 54.71 M-106.57 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 54.71 M-106.57 M — Basic earnings per share (Basic EPS) —— — Diluted earnings per share (Diluted EPS) —— — Average basic shares outstanding —— — Diluted shares outstanding —— — EBITDA —— — EBIT —— — Cost of revenue —— — Other cost of goods sold —— — Depreciation & amortization (cash flow) —— —